Production (Stage)
Envoy Medical, Inc.
COCH
$1.63
-$0.035-2.10%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -28.62% | -28.80% | 15.35% | 38.53% | 38.79% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -28.62% | -28.80% | 15.35% | 38.53% | 38.79% |
| Cost of Revenue | 10.43% | -2.37% | 20.97% | 38.22% | 13.54% |
| Gross Profit | -36.73% | -16.44% | -24.08% | -38.03% | -1.15% |
| SG&A Expenses | -13.71% | -4.30% | 50.56% | 54.88% | 110.58% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.47% | 4.24% | 46.92% | 53.02% | 81.68% |
| Operating Income | 0.04% | -4.81% | -47.44% | -53.26% | -82.54% |
| Income Before Tax | 14.55% | 30.29% | 42.13% | 65.54% | 16.32% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 14.55% | 30.29% | 42.13% | 65.54% | 16.32% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 14.55% | 30.29% | 42.13% | 65.54% | 16.32% |
| EBIT | 0.04% | -4.81% | -47.44% | -53.26% | -82.54% |
| EBITDA | 0.35% | -4.63% | -47.38% | -53.31% | -82.76% |
| EPS Basic | 26.66% | 45.86% | 61.61% | 77.29% | 25.83% |
| Normalized Basic EPS | 54.24% | 50.65% | 54.98% | 50.07% | -133.28% |
| EPS Diluted | 26.77% | 45.87% | 61.62% | 77.02% | 25.44% |
| Normalized Diluted EPS | 53.64% | 50.01% | 54.43% | 51.36% | -130.24% |
| Average Basic Shares Outstanding | 33.35% | 50.80% | 88.60% | 65.80% | -65.99% |
| Average Diluted Shares Outstanding | 31.08% | 47.79% | 84.06% | 68.27% | -65.40% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |